138 related articles for article (PubMed ID: 26547506)
1. Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis.
Salati S; Zini R; Nuzzo S; Guglielmelli P; Pennucci V; Prudente Z; Ruberti S; Rontauroli S; Norfo R; Bianchi E; Bogani C; Rotunno G; Fanelli T; Mannarelli C; Rosti V; Salmoiraghi S; Pietra D; Ferrari S; Barosi G; Rambaldi A; Cazzola M; Bicciato S; Tagliafico E; Vannucchi AM; Manfredini R;
Int J Cancer; 2016 Apr; 138(7):1657-69. PubMed ID: 26547506
[TBL] [Abstract][Full Text] [Related]
2. miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6.
Rontauroli S; Norfo R; Pennucci V; Zini R; Ruberti S; Bianchi E; Salati S; Prudente Z; Rossi C; Rosti V; Guglielmelli P; Barosi G; Vannucchi A; Tagliafico E; Manfredini R
Oncotarget; 2017 Mar; 8(13):21380-21397. PubMed ID: 28423484
[TBL] [Abstract][Full Text] [Related]
3. miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.
Norfo R; Zini R; Pennucci V; Bianchi E; Salati S; Guglielmelli P; Bogani C; Fanelli T; Mannarelli C; Rosti V; Pietra D; Salmoiraghi S; Bisognin A; Ruberti S; Rontauroli S; Sacchi G; Prudente Z; Barosi G; Cazzola M; Rambaldi A; Bortoluzzi S; Ferrari S; Tagliafico E; Vannucchi AM; Manfredini R;
Blood; 2014 Sep; 124(13):e21-32. PubMed ID: 25097177
[TBL] [Abstract][Full Text] [Related]
4. [The role of driver and subclonal mutations in pathogenesis of primary myelofibrosis].
Mózes R; Gángó A; Boha Z; Csomor J; Bödör C
Magy Onkol; 2017 Mar; 61(1):36-45. PubMed ID: 28273187
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in the treatment of myelofibrosis].
Takenaka K
Rinsho Ketsueki; 2020; 61(9):1195-1204. PubMed ID: 33162516
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A Review.
Alshemmari SH; Rajan R; Emadi A
Med Princ Pract; 2016; 25(6):501-509. PubMed ID: 27756071
[TBL] [Abstract][Full Text] [Related]
7. Copy number alterations and copy-neutral loss of heterozygosity in Ukrainian patients with primary myelofibrosis.
Poluben L; Bryke CR; Hsu Y; Shumeiko O; Neumerzhitska L; Klimuk B; Rybchenko L; Klymenko S; Balk SP; Fraenkel PG
Exp Oncol; 2019 Mar; 41(1):53-56. PubMed ID: 30932413
[TBL] [Abstract][Full Text] [Related]
8. Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis.
Rossi C; Zini R; Rontauroli S; Ruberti S; Prudente Z; Barbieri G; Bianchi E; Salati S; Genovese E; Bartalucci N; Guglielmelli P; Tagliafico E; Rosti V; Barosi G; Vannucchi AM; Manfredini R;
Mol Oncol; 2018 Dec; 12(12):2102-2123. PubMed ID: 30259659
[TBL] [Abstract][Full Text] [Related]
9. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management.
Tefferi A
Am J Hematol; 2021 Jan; 96(1):145-162. PubMed ID: 33197049
[TBL] [Abstract][Full Text] [Related]
10. Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis.
Bianchi E; Ruberti S; Rontauroli S; Guglielmelli P; Salati S; Rossi C; Zini R; Tagliafico E; Vannucchi AM; Manfredini R
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098757
[TBL] [Abstract][Full Text] [Related]
11. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2016 Dec; 91(12):1262-1271. PubMed ID: 27870387
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding myelofibrosis and essential thrombocythemia.
Vainchenker W; Constantinescu SN; Plo I
F1000Res; 2016; 5():. PubMed ID: 27134742
[TBL] [Abstract][Full Text] [Related]
13. Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis.
Bock O; Muth M; Theophile K; Winter M; Hussein K; Büsche G; Kröger N; Kreipe H
Br J Haematol; 2009 Sep; 146(5):510-20. PubMed ID: 19604240
[TBL] [Abstract][Full Text] [Related]
14. Canonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis.
Lucijanic M; Livun A; Tomasovic-Loncaric C; Stoos-Veic T; Pejsa V; Jaksic O; Prka Z; Kusec R
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):523-526. PubMed ID: 27381374
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients.
Masselli E; Carubbi C; Gobbi G; Mirandola P; Galli D; Martini S; Bonomini S; Crugnola M; Craviotto L; Aversa F; Vitale M
Leukemia; 2015 Nov; 29(11):2192-201. PubMed ID: 26183534
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the diagnosis and management of primary myelofibrosis.
Takenaka K; Shimoda K; Akashi K
Korean J Intern Med; 2018 Jul; 33(4):679-690. PubMed ID: 29665657
[TBL] [Abstract][Full Text] [Related]
17. ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF.
Triviai I; Zeschke S; Rentel J; Spanakis M; Scherer T; Gabdoulline R; Panagiota V; Thol F; Heuser M; Stocking C; Kröger N
Leukemia; 2019 Jan; 33(1):99-109. PubMed ID: 29907810
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome Analysis of Monozygotic Twin Brothers with Childhood Primary Myelofibrosis.
Ding N; Zhang Z; Yang W; Ren L; Zhang Y; Zhang J; Li Z; Zhang P; Zhu X; Chen X; Fang X
Genomics Proteomics Bioinformatics; 2017 Feb; 15(1):37-48. PubMed ID: 28185911
[TBL] [Abstract][Full Text] [Related]
19. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H
Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations of calreticulin in myeloproliferative neoplasms.
Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
